Pfizer's palace coup: The cast

With two CEO changes in five years, Pfizer has seen more than its share of conflict in its boardroom and executive suite. A guide to the players.

Jeff Kindler
CEO and chairman, 7/2006 - 12/2010

A star litigator, Kindler came to Pfizer as general counsel, than prevailed in a brutal three-way competition to succeed Hank McKinnell as CEO. A rare outsider at Pfizer's helm, he was charged with instilling new thinking at the company. Kindler made a giant acquisition and reorganized research. But his style and temperament led members of his own team to rebel. With two senior executives threatening to leave, he stepped down in December 2010.

By Peter Elkind and Jennifer Reingold with Doris Burke - Last updated July 28 2011: 5:47 AM ET
Join the Conversation
The war over Lipitor

India's Ranbaxy won the right to make a generic version -- only to be accused of serious fraud and shoddy practices in another case.

Most Popular

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.